Chris Boshoff Chief Development Officer Oncology had the honor of helping plan the NYASciences Frontiers in Cancer Immunotherapy Symposium where experts discussed cutting edge findings in the broad area of combo therapies. immunotherapy2019 httpb

Chris Boshoff, Chief Development Officer, Oncology, had the honor of helping plan the @NYASciences Frontiers in Cancer Immunotherapy Symposium where experts discussed cutting edge findings in the broad area of combo therapies. #immunotherapy2019 http://b

Chris Boshoff, Chief Development Officer, Oncology, had the honor of helping plan the @NYASciences Frontiers in Cancer Immunotherapy Symposium where experts discussed cutting edge findings in the broad area of combo therapies. #immunotherapy2019 http://bit.ly/2YA9zIx  pic.twitter.com/s2v2pVSjEv

More From BioPortfolio on "Chris Boshoff, Chief Development Officer, Oncology, had the honor of helping plan the @NYASciences Frontiers in Cancer Immunotherapy Symposium where experts discussed cutting edge findings in the broad area of combo therapies. #immunotherapy2019 http://b"